Nuzenio

Lifesci Capital Maintains

Lifesci Capital Maintains news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 3 publisher sources 100/100 entity strength

Latest news

LifeSci Capital Maintains Oculis(OCS.US) With Buy Rating, Maintains Target Price $41 - MoomooMoomoo · Sat, 08 Aug 2026 22:43:16 GMT Analyst Maintains Buy on Janux Therapeutics, Keeps $60 Price Target Unchanged on Strong Balance Sheet and Clinical Differentiation - TipRanksTipRanks · Fri, 07 Aug 2026 21:07:19 GMT Sam Slutsky Reiterates Buy Rating on Damora Therapeutics, Maintains $45 Price Target on Promising DMR-001 Profile - TipRanksTipRanks · Thu, 06 Aug 2026 14:02:06 GMT RBC Capital Keeps Their Buy Rating on Contineum Therapeutics, Inc. Class A (CTNM) - The Globe and MailThe Globe and Mail · Sat, 01 Aug 2026 13:06:00 GMT LifeSci Capital Maintains TScan Therapeutics(TCRX.US) With Buy Rating, Maintains Target Price $6 - MoomooMoomoo · Wed, 29 Jul 2026 20:31:00 GMT

Timeline

Sat, 08 Aug 2026 22:43:16 GMTLifeSci Capital Maintains Oculis(OCS.US) With Buy Rating, Maintains Target Price $41 - Moomoo

Fri, 07 Aug 2026 21:07:19 GMTAnalyst Maintains Buy on Janux Therapeutics, Keeps $60 Price Target Unchanged on Strong Balance Sheet and Clinical Differentiation - TipRanks

Thu, 06 Aug 2026 14:02:06 GMTSam Slutsky Reiterates Buy Rating on Damora Therapeutics, Maintains $45 Price Target on Promising DMR-001 Profile - TipRanks

Sat, 01 Aug 2026 13:06:00 GMTRBC Capital Keeps Their Buy Rating on Contineum Therapeutics, Inc. Class A (CTNM) - The Globe and Mail

Wed, 29 Jul 2026 20:31:00 GMTLifeSci Capital Maintains TScan Therapeutics(TCRX.US) With Buy Rating, Maintains Target Price $6 - Moomoo

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

With Buy Rating4 live mentions Maintains Target Price4 live mentions OCS2 live mentions Moomoo LifeSci Capital2 live mentions Moomoo Moomoo2 live mentions Janux Therapeutics2 live mentions Keeps2 live mentions Price Target Unchanged2 live mentions Strong Balance Sheet2 live mentions Damora Therapeutics2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Lifesci Capital Maintains.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.